Caricamento...

Iterative Design of Emetine-Based Prodrug Targeting Fibroblast Activation Protein (FAP) and Dipeptidyl Peptidase IV DPPIV Using a Tandem Enzymatic Activation Strategy

BACKGROUND. There is an urgent need to develop new agents for treating metastatic prostate cancer to overcome multiple drug resistance to the current standard targeted cancer therapy. Emetine is a highly cytotoxic natural product protein synthesis inhibitor, which is toxic to all cell types. Its cyt...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Prostate
Autori principali: Akinboye, Emmanuel S., Brennen, W. Nathaniel, Rosen, D. Marc, Bakare, Oladapo, Denmeade, Samuel R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6432629/
https://ncbi.nlm.nih.gov/pubmed/26835873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23162
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !